The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study-Reference-Cited by-同舟云学术

The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study

Published:2018-10-24 Issue:3 Volume:30 Page:675-683
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Takács I.,Jókai E.^ORCID,Kováts D. E.,Aradi I.

Funder

Gedeon Richter

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00198-018-4741-0.pdf

Reference26 articles.

1. Mitlak BH (2002) Parathyroid hormone as a therapeutic agent. Curr Opin Pharmacol 2:694–699

2. Gonzalez MJ, Olmos MJM (2010) Physiopathology of osteoporosis and the action mechanism of PTH. Rev Osteoporos Metab Miner 2(S2):S5–S17

3. Dobnig H (2004) A review of teriparatide and its clinical efficacy in the treatment of osteoporosis. Expert Opin Pharmacother 5(5):1153–1162

4. Gagnon C, Li V, Ebeling PR (2008) Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. Clin Interv Aging 3(4):635–645

5. Bilezikian JP (2008) Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window. Curr Osteoporos Rep 6:24–30

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER® and high-resolution peripheral computer tomography in postmenopausal women with osteoporosis and very high fracture risk;Osteoporosis International;2024-08-02

2. Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA Assessments;Pharmaceutical Medicine;2024-04-29

3. Anabolic Agents in the Treatment of Postmenopausal Osteoporosis;Endocrinology;2024

4. Therapeutic Peptides: Unravelling Conformational Dynamics by Systematic Application of Biophysical Techniques;Current Protein & Peptide Science;2022-09

5. Pharmacokinetics and Bioequivalence of 2 Azithromycin Tablet Formulations: A Randomized, Open‐Label, 2‐Stage Crossover Study in Healthy Volunteers;Clinical Pharmacology in Drug Development;2022-04-08